Wall Street brokerages predict that Patheon NV (NASDAQ:PTHN) will report earnings per share (EPS) of $0.32 for the current fiscal quarter, according to Zacks. Seven analysts have provided estimates for Patheon NV’s earnings, with the lowest EPS estimate coming in at $0.27 and the highest estimate coming in at $0.34. Patheon NV reported earnings per share of $0.07 during the same quarter last year, which indicates a positive year over year growth rate of 357.1%. The business is expected to issue its next earnings results on Monday, January 1st.

According to Zacks, analysts expect that Patheon NV will report full year earnings of $1.03 per share for the current financial year, with EPS estimates ranging from $1.01 to $1.05. For the next financial year, analysts expect that the company will report earnings of $1.39 per share, with EPS estimates ranging from $1.36 to $1.44. Zacks Investment Research’s earnings per share averages are an average based on a survey of sell-side analysts that that provide coverage for Patheon NV.

Patheon NV (NASDAQ:PTHN) last issued its quarterly earnings data on Thursday, June 8th. The company reported $0.20 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.19 by $0.01. The company had revenue of $483.40 million during the quarter, compared to the consensus estimate of $466.08 million. The business’s revenue was up 3.2% on a year-over-year basis.

A number of analysts have recently issued reports on PTHN shares. Zacks Investment Research lowered shares of Patheon NV from a “buy” rating to a “hold” rating in a research note on Thursday, June 15th. Raymond James Financial, Inc. reissued a “market perform” rating and set a $35.00 target price on shares of Patheon NV in a research note on Thursday, June 8th. J P Morgan Chase & Co downgraded Patheon NV from an “overweight” rating to a “neutral” rating in a report on Thursday, June 8th. Jefferies Group LLC downgraded Patheon NV from a “buy” rating to a “hold” rating and lifted their price objective for the company from $32.00 to $35.00 in a report on Tuesday, May 16th. Finally, Leerink Swann downgraded Patheon NV from an “outperform” rating to a “market perform” rating and lifted their price objective for the company from $31.00 to $35.00 in a report on Friday, June 9th. Seven analysts have rated the stock with a hold rating and one has issued a buy rating to the company’s stock. The company has an average rating of “Hold” and a consensus target price of $34.50.

TRADEMARK VIOLATION WARNING: “Brokerages Anticipate Patheon NV (PTHN) Will Post Earnings of $0.32 Per Share” was posted by American Banking News and is owned by of American Banking News. If you are reading this news story on another website, it was illegally stolen and reposted in violation of U.S. and international trademark & copyright law. The legal version of this news story can be read at https://www.americanbankingnews.com/2017/08/18/brokerages-anticipate-patheon-nv-pthn-will-post-earnings-of-0-32-per-share.html.

Institutional investors have recently made changes to their positions in the company. Public Employees Retirement System of Ohio increased its position in shares of Patheon NV by 273.1% in the second quarter. Public Employees Retirement System of Ohio now owns 41,916 shares of the company’s stock worth $1,462,000 after buying an additional 30,680 shares in the last quarter. Arrowstreet Capital Limited Partnership purchased a new position in shares of Patheon NV during the second quarter worth approximately $2,013,000. CNH Partners LLC purchased a new position in shares of Patheon NV during the second quarter worth approximately $46,539,000. BlueCrest Capital Management Ltd purchased a new position in shares of Patheon NV during the second quarter worth approximately $1,172,000. Finally, Goldman Sachs Group Inc. increased its position in shares of Patheon NV by 29.9% in the second quarter. Goldman Sachs Group Inc. now owns 130,327 shares of the company’s stock worth $4,546,000 after buying an additional 30,034 shares in the last quarter.

Patheon NV (NASDAQ PTHN) opened at 34.95 on Friday. The company has a market capitalization of $5.07 billion and a price-to-earnings ratio of 44.81. Patheon NV has a 52 week low of $23.72 and a 52 week high of $35.10. The company has a 50 day moving average of $34.92 and a 200 day moving average of $31.42.

Patheon NV Company Profile

Patheon N.V. is a provider of outsourced pharmaceutical development and manufacturing services. The Company’s segments include Drug Product Services (DPS), Pharmaceutical Development Services (PDS) and Drug Substance Services (DSS). The DPS segment is engaged in manufacturing and packaging for approved prescription, over-the-counter (OTC) and nutritional products.

Get a free copy of the Zacks research report on Patheon NV (PTHN)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Patheon NV Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Patheon NV and related companies with MarketBeat.com's FREE daily email newsletter.